Liberia vs Senegal: HIV/AIDS deaths averted by antiretroviral therapy
Liberia
1,934 deaths
in 2024
Senegal
2,002 deaths
in 2024
Liberia rank
60th
Senegal rank
57th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Liberia
- Senegal
How they compare
Senegal currently reports 2,002 deaths against 1,934 deaths in Liberia, a difference of 68 deaths.
The two have swapped places 4 times across 35 shared years of data; in 1990 it was Senegal ahead.
Liberia ranks 60th and Senegal ranks 57th of 157 countries.
Senegal has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Liberia | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 158.04 deaths | 481.41 deaths | 323.37 deaths | Senegal |
| 2010s | 977.16 deaths | 1,757 deaths | 779.82 deaths | Senegal |
| 2020s | 1,790 deaths | 1,992 deaths | 202.26 deaths | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Liberia or Senegal?
- Senegal, at 2,002 deaths against 1,934 deaths in Liberia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Liberia and Senegal?
- 68 deaths, with Senegal ahead.
- How many years of comparable data are there for Liberia and Senegal?
- 35 years are reported by both, from 1990 to 2024.
- How do Liberia and Senegal rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Liberia ranks 60th and Senegal ranks 57th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.